Gareth, that is sad. Using the AGM to lull you off to sleep!
SRX know the daily sales numbers. In 2014 at the AGM they announced dose sales up to the day before, for the year to date. As they should do. I'm still not convinced about the 'lumpy' numbers on the 1/4 reports, but it is what it is I guess.
As for the board, yes I went to the 2014 and got almost cut off by Hill. He is one arrogant and conceited SOB at times. There is a need to start the rotation process to bring in some new blood, over a period of time.
Reimbursement - have not heard of anything. Last info I had was about $16k US$ per treatment. And nearer $12k US for the EuroZone. I suspect Aussie sales are nearer $10k US.
'Also looking through the AGM they talk about hedging and Forex risk' - I think I recall Gilman saying they do not hedge. I have no real insight into how they manage this, but would assume funds are transferred on a weekly / monthly basis.
SRX Price at posting:
$40.77 Sentiment: Buy Disclosure: Held
